These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1974131)

  • 1. Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.
    Sklaviadis T; Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1990; 112(3-4):215-28. PubMed ID: 1974131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.
    Akowitz A; Manuelidis EE; Manuelidis L
    Arch Virol; 1993; 130(3-4):301-16. PubMed ID: 8517790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.
    Akowitz A; Sklaviadis T; Manuelidis L
    Nucleic Acids Res; 1994 Mar; 22(6):1101-7. PubMed ID: 8152913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies.
    Manuelidis L
    Ann N Y Acad Sci; 1994 Jun; 724():259-81. PubMed ID: 8030947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants.
    Bendheim PE; Bockman JM; McKinley MP; Kingsbury DT; Prusiner SB
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):997-1001. PubMed ID: 2579394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations.
    Akowitz A; Sklaviadis T; Manuelidis EE; Manuelidis L
    Microb Pathog; 1990 Jul; 9(1):33-45. PubMed ID: 1706452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation.
    Sklaviadis T; Dreyer R; Manuelidis L
    Virus Res; 1992 Dec; 26(3):241-54. PubMed ID: 1492497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.
    Sklaviadis T; Akowitz A; Manuelidis EE; Manuelidis L
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5713-7. PubMed ID: 8516321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acids in prion preparations: unspecific background or essential component?
    Kellings K; Prusiner SB; Riesner D
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):425-30. PubMed ID: 7913761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions--infectious pathogens causing the spongiform encephalopathies.
    Prusiner SB; Kingsbury DT
    CRC Crit Rev Clin Neurobiol; 1985; 1(3):181-200. PubMed ID: 3915974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical properties of the Creutzfeldt-Jakob disease agent.
    Sklaviadis TK; Manuelidis L; Manuelidis EE
    J Virol; 1989 Mar; 63(3):1212-22. PubMed ID: 2492609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoaffinity purification and neutralization of scrapie prion infectivity.
    Gabizon R; McKinley MP; Groth D; Prusiner SB
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6617-21. PubMed ID: 3137571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.
    Bockman JM; Prusiner SB; Tateishi J; Kingsbury DT
    Ann Neurol; 1987 Jun; 21(6):589-95. PubMed ID: 3300520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential retroviral RNAs in Creutzfeldt-Jakob disease.
    Murdoch GH; Sklaviadis T; Manuelidis EE; Manuelidis L
    J Virol; 1990 Apr; 64(4):1477-86. PubMed ID: 2108258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CJD and Scrapie Require Agent-Associated Nucleic Acids for Infection.
    Botsios S; Manuelidis L
    J Cell Biochem; 2016 Aug; 117(8):1947-58. PubMed ID: 26773845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD.
    Manuelidis L
    J Neurovirol; 2011 Apr; 17(2):131-45. PubMed ID: 21165784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.